相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。The role of adipokines in the rapid antidepressant effects of ketamine
R. Machado-Vieira et al.
MOLECULAR PSYCHIATRY (2017)
Genetic Contributions of Inflammation to Depression
Jacob Barnes et al.
NEUROPSYCHOPHARMACOLOGY (2017)
Inflammation, Glutamate, and Glia: A Trio of Trouble in Mood Disorders
Ebrahim Haroon et al.
NEUROPSYCHOPHARMACOLOGY (2017)
Change in cytokine levels is not associated with rapid antidepressant response to ketamine in treatment-resistant depression
Minkyung Park et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2017)
Altered peripheral immune profiles in treatment-resistant depression: response to ketamine and prediction of treatment outcome
D. D. Kiraly et al.
TRANSLATIONAL PSYCHIATRY (2017)
Effects of IL1B single nucleotide polymorphisms on depressive and anxiety symptoms are determined by severity and type of life stress
David Kovacs et al.
BRAIN BEHAVIOR AND IMMUNITY (2016)
Interleukin-6 promoter polymorphism interacts with pain and life stress influencing depression phenotypes
David Kovacs et al.
JOURNAL OF NEURAL TRANSMISSION (2016)
Conceptual convergence: increased inflammation is associated with increased basal ganglia glutamate in patients with major depression
E. Haroon et al.
MOLECULAR PSYCHIATRY (2016)
NMDAR inhibition-independent antidepressant actions of ketamine metabolites
Panos Zanos et al.
NATURE (2016)
BDNF - a key transducer of antidepressant effects
Carl Bjorkholm et al.
NEUROPHARMACOLOGY (2016)
Effectiveness of low-dose intravenous ketamine to attenuate stress response in patients undergoing emergency cesarean section with spinal anesthesia
Tjokorda Gde Agung Senapathi et al.
JOURNAL OF PAIN RESEARCH (2016)
The role of inflammation in depression: from evolutionary imperative to modern treatment target
Andrew H. Miller et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Peripheral proinflammatory markers associated with ketamine response in a preclinical model of antidepressant-resistance
Adam J. Walker et al.
BEHAVIOURAL BRAIN RESEARCH (2015)
Serum Interleukin-6 Is a Predictive Biomarker for Ketamine's Antidepressant Effect in Treatment-Resistant Patients With Major Depression
Jian-Jun Yang et al.
BIOLOGICAL PSYCHIATRY (2015)
Effects of chronic interpersonal stress exposure on depressive symptoms are moderated by genetic variation at IL6 and IL1β in youth
Margaret Tartter et al.
BRAIN BEHAVIOR AND IMMUNITY (2015)
Cumulative meta-analysis of interleukins 6 and 1β, tumour necrosis factor α and C-reactive protein in patients with major depressive disorder
Rita Haapakoski et al.
BRAIN BEHAVIOR AND IMMUNITY (2015)
Inflammation and clinical response to treatment in depression: A meta-analysis
R. Strawbridge et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2015)
Inflammatory Biomarkers as Differential Predictors of Antidepressant Response
Kenji Hashimoto
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Serum BDNF as a peripheral biomarker of treatment-resistant depression and the rapid antidepressant response: A comparison of ketamine and ECT
A. P. Allen et al.
JOURNAL OF AFFECTIVE DISORDERS (2015)
Neuroimmune mechanisms of depression
Georgia E. Hodes et al.
NATURE NEUROSCIENCE (2015)
NMDA receptor activation regulates sociability by its effect on mTOR signaling activity
Jessica A. Burket et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2015)
C-reactive protein gene variants: independent association with late-life depression and circulating protein levels
M-L Ancelin et al.
TRANSLATIONAL PSYCHIATRY (2015)
BDNF Release Is Required for the Behavioral Actions of Ketamine
Ashley E. Lepack et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2015)
Requirement of AMPA receptor stimulation for the sustained antidepressant activity of ketamine and LY341495 during the forced swim test in rats
Hiroyuki Koike et al.
BEHAVIOURAL BRAIN RESEARCH (2014)
Ketamine-induced antidepressant effects are associated with AMPA receptors-mediated upregulation of mTOR and BDNF in rat hippocampus and prefrontal cortex
W. Zhou et al.
EUROPEAN PSYCHIATRY (2014)
Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression
C. N. Haile et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2014)
Toll-like receptors in the depressed and suicide brain
Ghanshyam N. Pandey et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2014)
Mechanisms underlying differential effectiveness of memantine and ketamine in rapid antidepressant responses
Erinn S. Gideons et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Intranigral lipopolysaccharide induced anxiety and depression by altered BDNF mRNA expression in rat hippocampus
Lucian Hritcu et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2014)
A review of peripheral biomarkers in major depression: The potential of inflammatory and oxidative stress biomarkers
Adrian L. Lopresti et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2014)
Brain-derived neurotrophic factor: a bridge between inflammation and neuroplasticity
Francesca Calabrese et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2014)
Effect of Anti-inflammatory Treatment on Depression, Depressive Symptoms, and Adverse Effects A Systematic Review and Meta-analysis of Randomized Clinical Trials
Ole Kohler et al.
JAMA PSYCHIATRY (2014)
Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial
James W. Murrough et al.
AMERICAN JOURNAL OF PSYCHIATRY (2013)
The Role of Eukaryotic Elongation Factor 2 Kinase in Rapid Antidepressant Action of Ketamine
Lisa M. Monteggia et al.
BIOLOGICAL PSYCHIATRY (2013)
Activation of Mammalian Target of Rapamycin and Synaptogenesis: Role in the Actions of Rapid-Acting Antidepressants
Jason M. Dwyer et al.
BIOLOGICAL PSYCHIATRY (2013)
Rapid and Longer-Term Antidepressant Effects of Repeated Ketamine Infusions in Treatment-Resistant Major Depression
James W. Murrough et al.
BIOLOGICAL PSYCHIATRY (2013)
The role of immune genes in the association between depression and inflammation: A review of recent clinical studies
Chiara Bufalino et al.
BRAIN BEHAVIOR AND IMMUNITY (2013)
Tyrosine metabolism during interferon-alpha administration: Association with fatigue and CSF dopamine concentrations
Jennifer C. Felger et al.
BRAIN BEHAVIOR AND IMMUNITY (2013)
Ketamine and Peripheral Inflammation
Marc De Kock et al.
CNS NEUROSCIENCE & THERAPEUTICS (2013)
Cytokine gene variation is associated with depressive symptom trajectories in oncology patients and family caregivers
Laura B. Dunn et al.
EUROPEAN JOURNAL OF ONCOLOGY NURSING (2013)
CRP, IL-6 and depression: A systematic review and meta-analysis of longitudinal studies
Vyara Valkanova et al.
JOURNAL OF AFFECTIVE DISORDERS (2013)
Acute Suppression of Spontaneous Neurotransmission Drives Synaptic Potentiation
Elena Nosyreva et al.
JOURNAL OF NEUROSCIENCE (2013)
A recollection of mTOR signaling in learning and memory
Tyson E. Graber et al.
LEARNING & MEMORY (2013)
mTOR complexes in neurodevelopmental and neuropsychiatric disorders
Mauro Costa-Mattioli et al.
NATURE NEUROSCIENCE (2013)
Candidate Genes Expression Profile Associated with Antidepressants Response in the GENDEP Study: Differentiating between Baseline 'Predictors' and Longitudinal 'Targets'
Annamaria Cattaneo et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Conceptual Confluence: The Kynurenine Pathway as a Common Target for Ketamine and the Convergence of the Inflammation and Glutamate Hypotheses of Depression
Andrew H. Miller
NEUROPSYCHOPHARMACOLOGY (2013)
GSK-3 Inhibition Potentiates the Synaptogenic and Antidepressant-Like Effects of Subthreshold Doses of Ketamine
Rong-Jian Liu et al.
NEUROPSYCHOPHARMACOLOGY (2013)
NMDA Receptor Blockade by Ketamine Abrogates Lipopolysaccharide-Induced Depressive-Like Behavior in C57BL/6J Mice
Adam K. Walker et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Serotonin and interleukin-6: The role of genetic polymorphisms in IFN-induced neuropsychiatric symptoms
Marc Udina et al.
PSYCHONEUROENDOCRINOLOGY (2013)
Antidepressant effects of AMPA and ketamine combination: role of hippocampal BDNF, synapsin, and mTOR
Luli Akinfiresoye et al.
PSYCHOPHARMACOLOGY (2013)
Acute administration of ketamine in rats increases hippocampal BDNF and mTOR levels during forced swimming test
Chun Yang et al.
UPSALA JOURNAL OF MEDICAL SCIENCES (2013)
Ketamine exerts antidepressant effects and reduces IL-1β and IL-6 levels in rat prefrontal cortex and hippocampus
Chun Yang et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2013)
A Randomized Controlled Trial of the Tumor Necrosis Factor Antagonist Infliximab for Treatment-Resistant Depression
Charles L. Raison et al.
JAMA PSYCHIATRY (2013)
Does Intraoperative Ketamine Attenuate Inflammatory Reactivity Following Surgery? A Systematic Review and Meta-Analysis
Ola Dale et al.
ANESTHESIA AND ANALGESIA (2012)
Brain-Derived Neurotrophic Factor Val66Met Polymorphism and Antidepressant Efficacy of Ketamine in Depressed Patients
Gonzalo Laje et al.
BIOLOGICAL PSYCHIATRY (2012)
Interleukin (IL)-6, tumour necrosis factor alpha (TNF-α) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: A meta-analysis and meta-regression
Yang Liu et al.
JOURNAL OF AFFECTIVE DISORDERS (2012)
Proinflammatory cytokines in the prefrontal cortex of teenage suicide victims
Ghanshyam N. Pandey et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2012)
Towards a glutamate hypothesis of depression An emerging frontier of neuropsychopharmacology for mood disorders
Gerard Sanacora et al.
NEUROPHARMACOLOGY (2012)
Multigene interactions and the prediction of depression in the Wisconsin Longitudinal Study
Nicholas S. Roetker et al.
BMJ OPEN (2012)
Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression
Hiroyuki Koike et al.
BEHAVIOURAL BRAIN RESEARCH (2011)
The association between brain-derived neurotrophic factor polymorphism (BDNF Val66Met) and suicide
Peter Pregelj et al.
JOURNAL OF AFFECTIVE DISORDERS (2011)
Preliminary Findings Regarding Proinflammatory Markers and Brain-Derived Neurotrophic Factor Among Adolescents with Bipolar Spectrum Disorders
Benjamin I. Goldstein et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2011)
Comparison of Antidepressant Efficacy-related SNPs Among Taiwanese and Four Populations in the HapMap Database
Mei-Hung Chi et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2011)
Inhibition of glycogen synthase kinase-3 is necessary for the rapid antidepressant effect of ketamine in mice
E. Beurel et al.
MOLECULAR PSYCHIATRY (2011)
NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
Anita E. Autry et al.
NATURE (2011)
Effects of antipsychotic drugs on BDNF, GSK-3β, and β-catenin expression in rats subjected to immobilization stress
Sung Woo Park et al.
NEUROSCIENCE RESEARCH (2011)
The role of glutamate on the action of antidepressants
Kenji Hashimoto
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2011)
Rapid decrease in depressive symptoms with an N-methyl-D-aspartate antagonist in ECT-resistant major depression
Lobna Ibrahim et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2011)
The mTOR signaling pathway in the prefrontal cortex is compromised in major depressive disorder
Courtney S. Jernigan et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2011)
Genome-Wide Pharmacogenetics of Antidepressant Response in the GENDEP Project
Rudolf Uher et al.
AMERICAN JOURNAL OF PSYCHIATRY (2010)
A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar Depression
Nancy Diazgranados et al.
ARCHIVES OF GENERAL PSYCHIATRY (2010)
Association of Existing and New Candidate Genes for Anxiety, Depression and Personality Traits in Older People
Michelle Luciano et al.
BEHAVIOR GENETICS (2010)
The Interleukin 1 Beta (IL 1B) Gene Is Associated with Failure to Achieve Remission and Impaired Emotion Processing in Major Depression
Bernhard T. Baune et al.
BIOLOGICAL PSYCHIATRY (2010)
Inflammation-Induced Anhedonia: Endotoxin Reduces Ventral Striatum Responses to Reward
Naomi I. Eisenberger et al.
BIOLOGICAL PSYCHIATRY (2010)
Early Life Stress Combined with Serotonin 3A Receptor and Brain-Derived Neurotrophic Factor Valine 66 to Methionine Genotypes Impacts Emotional Brain and Arousal Correlates of Risk for Depression
Justine M. Gatt et al.
BIOLOGICAL PSYCHIATRY (2010)
A Meta-Analysis of Cytokines in Major Depression
Yekta Dowlati et al.
BIOLOGICAL PSYCHIATRY (2010)
Polymorphisms in the CRP gene moderate an association between depressive symptoms and circulating levels of C-reactive protein
Indrani Halder et al.
BRAIN BEHAVIOR AND IMMUNITY (2010)
Inflammation and social experience: An inflammatory challenge induces feelings of social disconnection in addition to depressed mood
Naomi I. Eisenberger et al.
BRAIN BEHAVIOR AND IMMUNITY (2010)
Rapid Resolution of Suicidal Ideation After a Single Infusion of an N-Methyl-D-Aspartate Antagonist in Patients With Treatment-Resistant Major Depressive Disorder
Nancy DiazGranados et al.
JOURNAL OF CLINICAL PSYCHIATRY (2010)
Depression-prone mice with reduced glucocorticoid receptor expression display an altered stress-dependent regulation of brain-derived neurotrophic factor and activity-regulated cytoskeleton-associated protein
R. Molteni et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2010)
Long-Term Duloxetine Treatment Normalizes Altered Brain-Derived Neurotrophic Factor Expression in Serotonin Transporter Knockout Rats through the Modulation of Specific Neurotrophin Isoforms
Francesca Calabrese et al.
MOLECULAR PHARMACOLOGY (2010)
Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders
Giles E. Hardingham et al.
NATURE REVIEWS NEUROSCIENCE (2010)
The BDNF Val66Met polymorphism and anxiety: Support for animal knock-in studies from a genetic association study in humans
Christian Montag et al.
PSYCHIATRY RESEARCH (2010)
mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
Nanxin Li et al.
SCIENCE (2010)
mTOR signaling: At the crossroads of plasticity, memory and disease
Charles A. Hoeffer et al.
TRENDS IN NEUROSCIENCES (2010)
The Role of Brain-Derived Neurotrophic Factor Genotype, Parental Depression, and Relationship Discord in Predicting Early-Emerging Negative Emotionality
Elizabeth P. Hayden et al.
PSYCHOLOGICAL SCIENCE (2010)
-308(G/A) TNF-alpha GENE POLYMORPHISM AND RISK OF DEPRESSION LATE IN THE LIFE
A. P. Cerri et al.
ARCHIVES OF GERONTOLOGY AND GERIATRICS (2009)
Inflammation Causes Mood Changes Through Alterations in Subgenual Cingulate Activity and Mesolimbic Connectivity
Neil A. Harrison et al.
BIOLOGICAL PSYCHIATRY (2009)
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Andrew H. Miller et al.
BIOLOGICAL PSYCHIATRY (2009)
Stress-induced dendritic remodeling in the medial prefrontal cortex: Effects of circuit, hormones and rest
Rebecca M. Shansky et al.
BRAIN RESEARCH (2009)
Cytokine Polymorphisms in the Pathophysiology of Mood Disorders
Mario Clerici et al.
CNS SPECTRUMS (2009)
Depression and Anxiety in Inflammatory Bowel Disease: A Review of Comorbidity and Management
Lesley A. Graff et al.
INFLAMMATORY BOWEL DISEASES (2009)
Polymorphisms of the CRP gene inhibit inflammatory response and increase susceptibility to depression: The Health in Men Study
Osvaldo P. Almeida et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2009)
Interaction between genetic polymorphisms and stressful life events in first episode depression
Jens Drachmann Bukh et al.
JOURNAL OF AFFECTIVE DISORDERS (2009)
Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-α and ribavirin treatment
S. J. Bull et al.
MOLECULAR PSYCHIATRY (2009)
Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice
J. C. O'Connor et al.
MOLECULAR PSYCHIATRY (2009)
The Met allele of the BDNF Val66Met polymorphism is associated with increased BDNF serum concentrations
U. E. Lang et al.
MOLECULAR PSYCHIATRY (2009)
Interleukin-1 Beta-511C/T Genetic Polymorphism is Associated with Age of Onset of Geriatric Depression
Jen-Ping Hwang et al.
NEUROMOLECULAR MEDICINE (2009)
Translational Control of Long-Lasting Synaptic Plasticity and Memory
Mauro Costa-Mattioli et al.
NEURON (2009)
Associations of Depression With C-Reactive Protein, IL-1, and IL-6: A Meta-Analysis
M. Bryant Howren et al.
PSYCHOSOMATIC MEDICINE (2009)
Serum brain-derived neurotrophic factor, depression, and antidepressant medications: Meta-analyses and implications
Srijan Sen et al.
BIOLOGICAL PSYCHIATRY (2008)
Cellular mechanisms underlying the antidepressant effects of ketamine:: Role of α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors
Sungho Maeng et al.
BIOLOGICAL PSYCHIATRY (2008)
Decreased levels of serum brain-derived neurotrophic factor in both depressed and euthymic patients with unipolar depression and in euthymic patients with bipolar I and II disorders
P. Monteleone et al.
BIPOLAR DISORDERS (2008)
Central effects of stress hormones in health and disease: Understanding the protective and damaging effects of stress and stress mediators
Bruce S. McEwen
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Polymorphisms in inflammation-related genes are associated with susceptibility to major depression and antidepressant response
M-L Wong et al.
MOLECULAR PSYCHIATRY (2008)
From inflammation to sickness and depression: when the immune system subjugates the brain
Robert Dantzer et al.
NATURE REVIEWS NEUROSCIENCE (2008)
BDNF genotype potentially modifying the association between incident stroke and depression
Jae-Min Kim et al.
NEUROBIOLOGY OF AGING (2008)
Cytokine Genes TNF, IL1A, IL1B, IL6, IL1RN and IL10, and Childhood-Onset Mood Disorders
V. L. Misener et al.
NEUROPSYCHOBIOLOGY (2008)
Cytokine-induced enhancement of calcium-dependent glutamate release from astrocytes mediated by nitric oxide
Tomoaki Ida et al.
NEUROSCIENCE LETTERS (2008)
Pro-inflammatory cytokines and treatment response to escitaloprsam in major depressive disorder
Triin Eller et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)
Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus
Leda S. B. Garcia et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)
Neuroinflammation and regulation of glial glutamate uptake in neurological disorders
Sebastien Tilleux et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2007)
UP inhibits LTD in the hippocampus via regulation of GSK3β
Stephane Peineau et al.
NEURON (2007)
The cationic amino acid transporters CAT1 and CAT3 mediate NMDA receptor activation-dependent changes in elaboration of neuronal processes via the mammalian target of rapamycin mTOR pathway
Yunfei Huang et al.
JOURNAL OF NEUROSCIENCE (2007)
The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior
Heath D. Schmidt et al.
BEHAVIOURAL PHARMACOLOGY (2007)
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression
Carlos A. Zarate et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
A neurotrophic model for stress-related mood disorders
Ronald S. Duman et al.
BIOLOGICAL PSYCHIATRY (2006)
Assessment of tumor necrosis factor alpha blockade as an intervention to improve tolerability of dose-intensive chemotherapy in cancer patients
JP Monk et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Basic fibroblast growth factor (bFGF, FGF-2) potentiates leukocyte recruitment to inflammation by enhancing endothelial adhesion molecule expression
SI Zittermann et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial
S Tyring et al.
LANCET (2006)
Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: Implications for clinical practice
MH Trivedi et al.
AMERICAN JOURNAL OF PSYCHIATRY (2006)
Cytokines sing the blues: inflammation and the pathogenesis of depression
CL Raison et al.
TRENDS IN IMMUNOLOGY (2006)
Mood disorders in the medically ill: Scientific review and recommendations
DL Evans et al.
BIOLOGICAL PSYCHIATRY (2005)
Mood alterations during interferon-alfa therapy in patients with chronic hepatitis C: Evidence for an overlap between manic/hypomanic and depressive symptoms
A Constant et al.
JOURNAL OF CLINICAL PSYCHIATRY (2005)
BDNF function in adult synaptic plasticity: The synaptic consolidation hypothesis
CR Bramham et al.
PROGRESS IN NEUROBIOLOGY (2005)
Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity
F Karege et al.
BIOLOGICAL PSYCHIATRY (2005)
Glutamate as a therapeutic target in psychiatric disorders
DC Javitt
MOLECULAR PSYCHIATRY (2004)
Brain-derived neurotrophic factor as a drug target for CNS disorders
S Pezet et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2004)
Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects
Y Dwivedi et al.
ARCHIVES OF GENERAL PSYCHIATRY (2003)
Association study of the interleukin-1 beta (C-511T) genetic polymorphism with major depressive disorder, associated symptomatology, and antidepressant response
WYY Younger et al.
NEUROPSYCHOPHARMACOLOGY (2003)
The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function
MF Egan et al.
CELL (2003)
Interleukine-6 serum levels correlate with response to antidepressant sleep deprivation and sleep phase advance
F Benedetti et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2002)
Neurobehavioral effects of interferon-α in cancer patients:: Phenomenology and paroxetine responsiveness of symptom dimensions
L Capuron et al.
NEUROPSYCHOPHARMACOLOGY (2002)
The neurobiology of stress: from serendipity to clinical relevance
BS McEwen
BRAIN RESEARCH (2000)
Cytokine production and treatment response in major depressive disorder
S Lanquillon et al.
NEUROPSYCHOPHARMACOLOGY (2000)
Antidepressant effects of ketamine in depressed patients
RM Berman et al.
BIOLOGICAL PSYCHIATRY (2000)